Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 31 | $53,693,258 |
| Sells | 12 | $3,814,353 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 24 Sep 2024 16:04 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 20 Sep 2024 | Purchase | 25,769 | 22.228 | 572,793 | I |
| 24 Sep 2024 16:04 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 20 Sep 2024 | Purchase | 47,564 | 21.474 | 1,021,389 | I |
| 24 Sep 2024 16:04 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 20 Sep 2024 | Purchase | 139,551 | 20.418 | 2,849,352 | I |
| 24 Sep 2024 16:04 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 20 Sep 2024 | Purchase | 66,088 | 19.611 | 1,296,052 | I |
| 24 Sep 2024 16:04 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 20 Sep 2024 | Purchase | 25,943 | 18.36 | 476,313 | I |
| 24 Sep 2024 16:04 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 20 Sep 2024 | Purchase | 45,085 | 17.475 | 787,860 | I |
| 18 Jun 2024 17:59 | CRBP | Corbus Pharmaceuticals Holdings Inc | MORAN SEAN F. | Chief Financial Officer | 18 Jun 2024 | Sale | 1,958 | 42.1242 | 82,479 | D |
| 18 Jun 2024 17:59 | CRBP | Corbus Pharmaceuticals Holdings Inc | MORAN SEAN F. | Chief Financial Officer | 17 Jun 2024 | Sale | 6,730 | 46.774 | 314,789 | D |
| 18 Jun 2024 17:59 | CRBP | Corbus Pharmaceuticals Holdings Inc | MORAN SEAN F. | Chief Financial Officer | 14 Jun 2024 | Sale | 7,788 | 49.8738 | 388,417 | D |
| 18 Jun 2024 17:59 | CRBP | Corbus Pharmaceuticals Holdings Inc | MORAN SEAN F. | Chief Financial Officer | 14 Jun 2024 | Sale | 1,567 | 49.8738 | 78,152 | D |
| 18 Jun 2024 17:58 | CRBP | Corbus Pharmaceuticals Holdings Inc | COHEN YUVAL | Chief Executive Officer | 18 Jun 2024 | Sale | 7,179 | 42.237 | 303,219 | D |
| 18 Jun 2024 17:58 | CRBP | Corbus Pharmaceuticals Holdings Inc | COHEN YUVAL | Chief Executive Officer | 18 Jun 2024 | Sale | 2,322 | 42.237 | 98,074 | D |
| 18 Jun 2024 17:58 | CRBP | Corbus Pharmaceuticals Holdings Inc | COHEN YUVAL | Chief Executive Officer | 18 Jun 2024 | Sale | 1,770 | 42.237 | 74,759 | D |
| 18 Jun 2024 17:58 | CRBP | Corbus Pharmaceuticals Holdings Inc | COHEN YUVAL | Chief Executive Officer | 18 Jun 2024 | Sale | 11,667 | 42.237 | 492,779 | D |
| 18 Jun 2024 17:58 | CRBP | Corbus Pharmaceuticals Holdings Inc | COHEN YUVAL | Chief Executive Officer | 17 Jun 2024 | Sale | 1,770 | 46.0203 | 81,456 | D |
| 18 Jun 2024 17:58 | CRBP | Corbus Pharmaceuticals Holdings Inc | COHEN YUVAL | Chief Executive Officer | 17 Jun 2024 | Sale | 9,333 | 46.0203 | 429,507 | D |
| 18 Jun 2024 17:58 | CRBP | Corbus Pharmaceuticals Holdings Inc | COHEN YUVAL | Chief Executive Officer | 14 Jun 2024 | Sale | 12,487 | 50.1662 | 626,425 | D |
| 18 Jun 2024 17:58 | CRBP | Corbus Pharmaceuticals Holdings Inc | COHEN YUVAL | Chief Executive Officer | 14 Jun 2024 | Sale | 16,830 | 50.1662 | 844,297 | D |
| 11 Mar 2024 17:34 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 08 Mar 2024 | Purchase | 8,862 | 45.96 | 407,298 | I |
| 11 Mar 2024 17:34 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 08 Mar 2024 | Purchase | 156,597 | 45.26 | 7,087,580 | I |
| 11 Mar 2024 17:34 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 08 Mar 2024 | Purchase | 61,668 | 44.62 | 2,751,626 | I |
| 11 Mar 2024 17:34 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 08 Mar 2024 | Purchase | 18,548 | 43.26 | 802,386 | I |
| 11 Mar 2024 17:34 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 08 Mar 2024 | Purchase | 24,983 | 42.25 | 1,055,532 | I |
| 11 Mar 2024 17:34 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 08 Mar 2024 | Purchase | 29,342 | 41.23 | 1,209,771 | I |
| 11 Mar 2024 17:34 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 07 Mar 2024 | Purchase | 102,140 | 41.23 | 4,211,232 | I |
| 11 Mar 2024 17:34 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 07 Mar 2024 | Purchase | 90,325 | 39.99 | 3,612,097 | I |
| 11 Mar 2024 17:34 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 07 Mar 2024 | Purchase | 10,736 | 39.13 | 420,100 | I |
| 11 Mar 2024 17:34 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 07 Mar 2024 | Purchase | 46,799 | 37.82 | 1,769,938 | I |
| 06 Feb 2024 16:00 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 02 Feb 2024 | Purchase | 750,000 | 19 | 14,250,000 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 3,200 | 38.49 | 123,168 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 43,754 | 37.49 | 1,640,337 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 16,484 | 36.53 | 602,161 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 32,295 | 35.83 | 1,157,130 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 18,055 | 33.71 | 608,634 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 31,549 | 34.62 | 1,092,226 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 3,866 | 32.47 | 125,529 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 4,125 | 31.86 | 131,422 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 2,654 | 31 | 82,274 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 29,244 | 29.42 | 860,358 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 31,028 | 28.82 | 894,227 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 36,747 | 27.7 | 1,017,892 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 14,388 | 25.73 | 370,203 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 15,243 | 26.66 | 406,378 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)